You are now viewing 1 - 4 of 4 results
December 1, 2007 | Program Result Report
The Manhattan Institute for Policy Research released a white paper with recommendations on how to reform the pipeline for new medications, including the approval process by the Food and Drug Administration (FDA).
January 11, 2012 | Story
Lynn Etheredge's Ideas Facilitate Policy to Improve Quality and Reduce Costs.
October 21, 2009 | Journal Article
This commentary calls for prescription medication labels to more accurately reflect FDA review documents. The FDA is considering adopting "Prescription Drug Facts Boxes" to supply crucial information now absent from many drug labels.
April 21, 2009 | Journal Article
This article examines whether providing a drug facts box on direct-to-consumer advertising can impact consumer understanding and decision-making.